3SBio (1530)

Currency in HKD
22.32
-0.62(-2.70%)
Closed·
1530 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.0822.84
52 wk Range
10.9436.80
Key Statistics
Bid/Ask
22.32 / 22.34
Prev. Close
22.94
Open
22.84
Day's Range
22.08-22.84
52 wk Range
10.94-36.8
Volume
16.44M
Average Volume (3m)
29.98M
1-Year Change
93.0796%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1530 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
37.44
Upside
+67.75%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

3SBio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Analyst Ratings

12 Buy
1 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 37.44
(+67.75% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Hold29.43+31.85%33.21Maintain03/04/2026
CLSA
Buy32.60+46.06%37.10Maintain01/04/2026
UBS
Buy41.00+83.69%-Maintain29/09/2025
Goldman Sachs
Hold29.22+30.91%25.81Maintain02/09/2025
CLSA
Buy37.10+66.22%19.60Maintain02/09/2025

Earnings

Latest Release
30/03/2026
EPS / Forecast
2.85 / --
Revenue / Forecast
13.34B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.43%
Dividend Yield
1.09%
Industry Median 2.46%
Annualised payout
0.25
Paid annually
5-Years Growth
-
Growth Streak

3SBio (1530) Income Statement & Profits

Compare 1530 to Peers and Sector

Metrics to compare
1530
Peers
Sector
Relationship
P/E Ratio
5.9x30.0x−0.5x
PEG Ratio
0.020.130.00
Price/Book
1.8x2.4x2.6x
Price / LTM Sales
2.8x5.0x3.2x
Upside (Analyst Target)
58.9%31.0%47.8%
Fair Value Upside
Unlock10.7%5.9%Unlock

3SBio Inc., an investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally. The company offers TPIAO bio-pharmaceutical drug for the treatment of chemotherapy-induced thrombocytopenia, immune thrombocytopenia, pediatric ITP, and chronic liver disease-related thrombocytopenia. It also provides EPIAO for indications, such as the treatment of anemia associated with chronic kidney disease, chemotherapy-induced anemia, and the reduction of allogeneic blood transfusion in surgery patients; and Yisaipu, a TNF-a inhibitor product for rheumatoid arthritis, ankylosing spondylitis, and psoriasis indications. In addition, the company offers Cipterbin, an anti-HER2 mAb for treatment of HER2-positive metastatic breast cancer in combination with chemotherapy; and Mandi, a minoxidil tincture for androgenetic alopecia and alopecia areata. Further, it develops 608, an anti-IL-17A mAb; SSS20 for patients with ITP and severe Aplastic Anemia; SSS06 for the treatment of adult dialysis patients undergoing erythropoietin therapy with a biweekly dosing interval; 613, for the treatment of acute gouty arthritis; 611, an anti-IL-4R a mAb; and 601A, an anti-VEGF mAb. Additionally, the company is involved in manufacture and sale of pharmaceutical drugs; business management; provision of technical services, investment advisory services, financial services, sports services, clinic services, technology services, and agricultural services; retail of pharmaceuticals; and enterprise management consulting. 3SBio Inc. was founded in 1993 and is headquartered in Shenyang, the People’s Republic of China.

Employees
6109
Market
Hong Kong

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
849.82M33.98%18.97B
Other Institutional Investors
778.95M31.15%17.39B
Public Companies & Retail Investors
871.88M34.87%19.46B
Total
2.5B100.00%55.81B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Century Sunshine Limited19.07%476,774,55310,641,608
China Universal Asset Management Company Ltd.7.16%179,164,5003,998,952

People Also Watch

16.54
NWLF
+0.55%
17.90
0780
+0.34%
4.390
3998
+0.92%
4.40
1368
0.00%

FAQ

What Is the 3SBio (Hong Kong: 1530) Share Price Today?

The 3SBio stock price today is 22.32 HKD.

What Stock Exchange Does 3SBio (1530) Trade On?

3SBio is listed and trades on the Hong Kong Stock Exchange.

What Is the Ticker (Stock Symbol) for 3SBio?

The stock symbol (also called a 'ticker') for 3SBio is "1530."

Does 3SBio Pay Dividends? What’s The Current 1530 Dividend Yield?

Yes, 1530 Pays Dividends to its Shareholders. The current 3SBio dividend yield is 1.09%.

What Is the Current 3SBio Market Capitalisation?

As of today, 3SBio (Hong Kong: 1530) market cap is 55.81B HKD.

What Is 3SBio's (1530) Earnings Per Share (TTM)?

The 3SBio EPS is currently 3.43 (Trailing Twelve Months).

Is 1530 a Buy or Sell From a Technical Analyst Perspective?

Based on today's 3SBio moving averages and other technical indicators, the daily buy/sell signal for 1530 stock is Strong Sell.

How Many Times Has 3SBio Stock Split?

3SBio has split 0 times. (See the 1530 stock split history page for full effective split date and price information.)

How Many Employees Does 3SBio Have?

3SBio has 6109 employees, based on their latest Companies House report.

What is the current trading status of 3SBio (Hong Kong: 1530)?

As of 09/05/2026, 3SBio (1530) is trading at a share price of 22.32 HKD, with a previous close of 22.94 HKD. The stock has fluctuated within a day range of 22.08 HKD to 22.84 HKD, while its 52-week range spans from 10.94 HKD to 36.80 HKD.

What Is 3SBio (1530) Price Target According to Analysts?

The average 12-month price target for 3SBio is 37.44 HKD, with a high estimate of 50.0264672 HKD and a low estimate of 25.82048331 HKD. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +67.75% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.